BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noor NM, Parkes M, Raine T. Moving towards more patient-centred clinical trials in IBD. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34312526 DOI: 10.1038/s41575-021-00500-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sedano R, Hogan M, Mcdonald C, Aswani-omprakash T, Ma C, Jairath V. Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab362] [Reference Citation Analysis]
2 Agrawal M, Verstockt B. Etrolizumab for ulcerative colitis: beyond what meets the eye. Lancet Gastroenterol Hepatol 2022;7:2-4. [PMID: 34798035 DOI: 10.1016/S2468-1253(21)00369-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Nguyen NH, Martinez I, Atreja A, Sitapati AM, Sandborn WJ, Ohno-Machado L, Singh S. Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic Review. Am J Gastroenterol 2021. [PMID: 34751673 DOI: 10.14309/ajg.0000000000001545] [Cited by in F6Publishing: 2] [Reference Citation Analysis]